How to Use Low-Dose Atropine to Slow Myopic Progression in Kids
2016年12月1日 · Low-dose atropine (0.01%) has emerged as an effective approach, as highlighted by the Atropine in the Treatment of Myopia studies (ATOM1 and ATOM2). 3-7 Although ATOM enrolled Asian patients, studies are now under way involving other populations.
Atropine 0.05% over 0.01% in myopia control: study - AOA
2020年3月30日 · Published in the journal Ophthalmology, the study crowned 0.05% atropine the optimal concentration for longer-term myopia control over 0.01% atropine after observing greater efficacy without any apparent adverse effects on quality of life (QOL).
Low-Dose Atropine for Myopia Control - American Academy of Ophthalmology
2023年7月1日 · Bullimore and Brennan sought to predict the three-year efficacy of low-dose atropine by assessing results of the low-concentration atropine for myopia progression (LAMP) study and by reviewing a meta-analysis of 80 studies of axial length in untreated myopic children.
The Role of Atropine in Preventing Myopia Progression: An Update
Topical 0.01% Atropine for the Control of Fast Progressing Myopia (Myopie-STOP), with the aim of evaluating the efficacy at 1 year of 0.01% atropine on the reduction of fast progressing myopia in children aged 4–12, compared to a placebo .
Atropine Eye Drops for Myopia Control in Childhood—More …
The Atropine Treatment Long-Term Assessment Study (ATLAS) has provided important very-long-term outcome data concerning the effectiveness and safety for prescribing various concentrations of atropine eye drops (0.01%, 0.1%, 0.5%, and 1.0%) for myopia control. 1 The study findings affirm the importance of randomized short-term treatment trials ...
Efficacy and Safety of 8 Atropine Concentrations for Myopia Control …
2021年6月12日 · Our NMA ranked the 1%, 0.5%, and 0.05% atropine concentrations as the 3 most beneficial for myopia control, as assessed for both primary outcomes: 1% atropine (mean differences compared with control: refraction, 0.81 [95% confidence interval (CI), 0.58–1.04]; AXL, –0.35 [–0.46 to –0.25]); 0.5% atropine (mean differences compared with ...
Low-Dose Atropine to Slow Myopia: Evidence and Adoption Are Growing
2021年8月1日 · The ATOM1 study found atropine to be superior to placebo, and ATOM2 found that low dosages also slowed the progression of myopia. The LAMP study used a range of low dosages of atropine to see which was most effective.
Update in myopia and treatment strategy of atropine use in myopia control
2018年6月11日 · Atropine is currently the most effective therapy for myopia control. Recent clinical trials demonstrated low-dose atropine eye drops such as 0.01% resulted in retardation of myopia...
Low concentration atropine and myopia: a narrative review of the ...
2023年9月16日 · Pharmacological control of myopia progression with atropine has been investigated since the 19th century and the benefits of slowing myopia progression are considered against the side-effects...
Atropine, 0.01%, for Myopia Control | Ophthalmology | JAMA ...
Overall, clinical trials investigating atropine, 0.01%, for myopia control, including the well-done study by Repka et al, 7 indicate that stronger concentrations of atropine should be considered for first-line treatment of myopia progression, especially when considering eye growth outcomes in …